光对神经退行性疾病的生物活性:不同活性化合物和病理标志之间的相互作用
Wenhui Lian1, Xu Yang1, Qidong Duan1
1Jilin Ginseng Academy, Changchun University of Traditional Chinese Medicine, Changchun 130117, China.
Molecules (Basel, Switzerland)
|June 19, 2024
概括
药用Ganoderma lucidum在神经退行性疾病方面表现有前途. 它的化合物,如多糖和甘酸,通过减少炎症和向疾病机制来提供神经保护.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 菌类学 菌类学是指菌类学.
背景情况:
- 神经退行性疾病涉及进步的神经系统损伤与有限的治疗.
- 药用如Ganoderma lucidum拥有具有潜在神经保护作用的生物活性化合物.
研究的目的:
- 审查Ganoderma lucidum的生物活性化合物及其对神经退行性疾病特征的影响.
- 详细介绍化合物结构,制备和未来研究和药物开发的机制.
主要方法:
- 对现有研究的文献综述 Ganoderma lucidum 提取物和化合物.
- 分析结构信息和准备关键组件的过程.
- 对神经退行性病理的作用机制的分类.
主要成果:
- 光的化合物表现出抗炎和抗氧化性质.
- 多糖体表现出神经营养效应.
- 甘酸向致病性蛋白质并调节自.
结论:
- 光的化合物显示出神经退行性疾病中神经保护的潜力.
- 需要进行进一步的临床试验,以验证这些发现是否适用于新药开发.
相关概念视频
Alzheimer's Disease: Overview
462
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
462
Parkinson's Disease: Overview
524
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
524
Alzheimer's Disease: Treatment
179
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
179
Neural Regulation
39.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.3K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
120
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
120
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K


